Used as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs) for antidepressant medications. It serves in the production of pharmaceuticals targeting central nervous system disorders, particularly in developing compounds with improved metabolic stability and receptor selectivity. Its structure supports the creation of chiral active ingredients, making it valuable in asymmetric synthesis for drug development. Also utilized in research settings to design novel psychoactive agents and evaluate their pharmacological profiles.